PubMed · 1177379
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
J Mücke, W Braun. 1975. [Current therapeutic problems in hyperbilirubinemia].. https://pubmed.ncbi.nlm.nih.gov/1177379/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
The hemoglobinopathies are a heterogeneous group of single-gene disorders that includes the structural hemoglobin variants and the thalassemias. More than 270 million people worldwide are heterozygous carriers of hereditary disorders of hemoglobin, and at least 300,000 affected homozygotes or compound heterozygotes are born each year. The purpose of this document is to review the most common hemoglobinopathies and to provide recommendations for screening and clinical management of hemoglobinopathies during pregnancy.
Explore the source record for details and available documents.
In the newborn period, unconjugated hyperbilirubinemia (UHB) is common, multifactoral, and associated with a variety of physiologic and pathologic conditions. The most commonly identified pathologic cause leading to hyperbilirubinemia is hemolytic disease of the newborn. We report a five-days-old female infant with neonatal jaundice secondary to splenic hematoma.